초록 ▼

The present invention provides an effective, all-natural, non-toxic, non-hormonal composition consisting of vitamin D3, vitamin E, selenium, green tea extract, saw palmetto berry extract, isoflavanoids, and lycopene for prostate health. The invention provides compositions and methods to prevent, all

The present invention provides an effective, all-natural, non-toxic, non-hormonal composition consisting of vitamin D3, vitamin E, selenium, green tea extract, saw palmetto berry extract, isoflavanoids, and lycopene for prostate health. The invention provides compositions and methods to prevent, alleviate, and/or treat symptoms associated with prostate conditions and diseases. The prostate health composition may be used to supplement medical treatment such as radiation therapy, chemotherapy, and hormone therapy.

대표청구항 ▼

1. A method for improving prostate health, comprising: administering to a human a composition comprising in an effective daily dosage:at least about 200 International Units (IU) of cholecalciferol;at least about 200 IU of D-alpha tocopherol;at least about 100 micrograms (μg) of selenium as L-selenom

1. A method for improving prostate health, comprising: administering to a human a composition comprising in an effective daily dosage:at least about 200 International Units (IU) of cholecalciferol;at least about 200 IU of D-alpha tocopherol;at least about 100 micrograms (μg) of selenium as L-selenomethionine;at least about 200 milligrams (mg) of epigallocatechin;at least about 160 mg of saw palmetto berry extract;at least about 10 mg of daidzein;at least about 10 mg of genistein;at least about 10 mg of glycitein; andat least about 5 mg of lycopene,wherein the effective daily dosage of the composition reduces severity of at least one symptom associated with a prostate condition and/or disease, the symptom selected from the group consisting of frequent urination, urgency of urination, urinary hesitancy, weak urination, urinary blockage, urinary leakage, urinary dribbling, night urination, prostatitis, elevated prostate specific antigen levels, tumor cells, enlarged prostate, benign prostate hyperplasia, prostate cancer, and combinations thereof. 2. The method according to claim 1, wherein the effective daily dosage of the composition is administered in about 1 to about 8 individual doses for a period of time sufficient to provide improvement in the at least one symptom. 3. The method according to claim 1, wherein the composition is administered in an effective daily dosage to reduce a rate of prostate specific antigen (PSA) level elevation. 4. The method according to claim 1, wherein the composition is administered as an adjuvant to radiation therapy, chemotherapeutic agents, or a combination thereof. 5. The method according to claim 1, wherein the composition is administered in an effective daily dosage to alleviate at least one symptom associated with benign prostate hyperplasia. 6. The method according to claim 1, wherein the composition is administered in an effective daily dosage to reduce PSA levels in the human. 7. The method according to claim 1, wherein the composition is administered orally. 8. The method according to claim 1, wherein the composition is administered to a patient having a recurrence of prostate cancer in an effective daily dosage to lower elevated PSA levels. 9. The method according to claim 1, wherein the composition is administered to a patient having a recurrence of prostate cancer in an effective daily dosage to reduce proliferation of prostate cancer cells. 10. A method for reducing a rate of elevation of prostate serum antigen (PSA) in a patient having recurrence of prostate cancer, comprising: administering to the patient a composition comprising in an effective daily dosage at least about 200 International Units (IU) cholecalciferol, at least about 200 IU of D-alpha tocopherol, at least about 100 micrograms (μg) of selenium, at least about 200 milligrams (mg) of epigallocatechin, at least about 160 mg of saw palmetto berry extract, at least about 10 mg of at least one isoflavonoid compound selected from the group consisting of daidzein, genistein, and glycitein, and at least about 5 mg of lycopene, wherein the rate of elevation of PSA is reduced. 11. The method according to claim 10, wherein the effective daily dosage of the composition comprises: about 200 IU to about 1200 IU of cholecalciferol;about 200 IU to about 1200 IU of D alpha tocopherol;about 100 mcg to about 600 μg of selenium;about 200 mg to about 1200 mg of epigallocatechin;about 160 mg to about 960 mg of saw palmetto berry extract;about 10 mg to about 60 mg of daidzein;about 10 mg to about 60 mg of genistein;about 10 mg to about 60 mg of glycitein; andabout 5 mg to about 30 mg of lycopene. 12. The method according to claim 10, wherein the composition is administered orally. 13. The method according to claim 10, wherein the composition further comprises one or more of vitamin A, vitamin C, silica, magnesium, maltodextrin, and soy proteins. 14. The method according to claim 10, wherein the composition is administered in combination with chemotherapeutic agents, radiation therapy, or a combination thereof. 15. A method for reducing elevated prostate serum antigen (PSA) levels in a human subject, comprising: administering to the human subject a composition comprising in an effective daily dosage at least about 200 International Units (IU) cholecalciferol, at least about 200 IU of D-alpha tocopherol, at least about 100 micrograms (μg) of selenium, at least about 200 milligrams (mg) of epigallocatechin, at least about 160 mg of saw palmetto berry extract, at least about 10 mg of at least one isoflavonoid compound selected from the group consisting of daidzein, genistein, and glycitein, and at least about 5 mg of lycopene, wherein the serum PSA level is reduced. 16. The method according to claim 15, wherein the composition comprises cholecalciferol; D-alpha tocopherol; selenium as L-selenomethionine; epigallocatechin; saw palmetto berry extract; daidzein; genistein; glycitein; and lycopene. 17. The method according to claim 15, wherein the effective daily dosage of the composition comprises: at least about 200 International Units (IU) of cholecalciferol;at least about 200 IU of D-alpha tocopherol;at least about 100 micrograms (μg) of selenium as L-selenomethionine;at least about 200 milligrams (mg) of epigallocatechin;at least about 160 mg of saw palmetto berry extract;at least about 10 mg of daidzein;at least about 10 mg of genistein;at least about 10 mg of glycitein; andat least about 5 mg of lycopene. 18. The method according to claim 15, wherein the effective daily dosage amount of the composition reduces elevated PSA levels in the human subject without decreasing serum testosterone levels. 19. The method according to claim 15, wherein the effective daily dosage is administered as 1 to 3 individual doses. 20. The method according to claim 19, wherein an individual dose comprises about 1 to 8 capsules, tablets, soft gels, or a combination thereof.